KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Colgate Palmolive (CL) Cash & Equivalents: 2009-2025

Historic Cash & Equivalents for Colgate Palmolive (CL) over the last 17 years, with Sep 2025 value amounting to $1.3 billion.

  • Colgate Palmolive's Cash & Equivalents rose 3.65% to $1.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 billion, marking a year-over-year increase of 3.65%. This contributed to the annual value of $1.1 billion for FY2024, which is 13.46% up from last year.
  • Colgate Palmolive's Cash & Equivalents amounted to $1.3 billion in Q3 2025, which was up 5.27% from $1.2 billion recorded in Q2 2025.
  • In the past 5 years, Colgate Palmolive's Cash & Equivalents ranged from a high of $1.3 billion in Q3 2025 and a low of $775.0 million during Q4 2022.
  • For the 3-year period, Colgate Palmolive's Cash & Equivalents averaged around $1.1 billion, with its median value being $1.1 billion (2024).
  • As far as peak fluctuations go, Colgate Palmolive's Cash & Equivalents fell by 11.86% in 2022, and later surged by 35.53% in 2024.
  • Quarterly analysis of 5 years shows Colgate Palmolive's Cash & Equivalents stood at $832.0 million in 2021, then fell by 6.85% to $775.0 million in 2022, then climbed by 24.65% to $966.0 million in 2023, then grew by 13.46% to $1.1 billion in 2024, then climbed by 3.65% to $1.3 billion in 2025.
  • Its Cash & Equivalents was $1.3 billion in Q3 2025, compared to $1.2 billion in Q2 2025 and $1.1 billion in Q1 2025.